唯亚威 VIAV 深 沪
等待开盘 12-17 09:30:00 美东时间
17.28
-0.600
-3.36%
华盛通- 最 高17.95
- 今 开17.52
- 成交量 477.03万股
- 最 低 16.9101
- 昨 收 17.88
- 总市值 38.53亿
- 52周最高 19.755
- 市盈率 静 112.06
- 换手率 2.14%
- 52周最低 8.10
- 委 比 69.50%
- 总股本 2.23亿
- 历史最高 19.755
- 量 比 1.02
- 振 幅 5.82%
- 历史最低 3.78
- 每 手 1
- 风险率 2.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Viavi Solutions Announces Convertible Notes Exchange Agreement
Viavi Solutions ( ($VIAV) ) just unveiled an announcement. On December 15, 2025...
12-16 20:28
Shares of companies within the broader technology sector are trading lower amid weakness in Broadcom after it issued cautious outlook. The sector is also being weighed down by reports that Oracle delayed some data center projects for OpenAI.
Shares of companies within the broader technology sector are trading lower amid...
12-13 04:20
Viavi Solutions and QNu Labs Join Forces to Build Quantum-Safe Security Tools for Future-Proof Networks
Viavi Solutions Inc. (VIAVI) (NASDAQ:VIAV) and QNu Labs, a global leader in hybrid quantum cybersecurity solutions, today announced a strategic partnership to develop cutting-edge quantum security and advanced
12-04 19:36
Here's Why Viavi Solutions (NASDAQ:VIAV) Can Manage Its Debt Responsibly
Howard Marks put it nicely when he said that, rather than worrying about share ...
11-08 02:59
Earnings Outlook For Viasat
Viasat (NASDAQ:VSAT) is gearing up to announce its quarterly earnings on Friday...
11-06 23:02
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
VIAVI Takes First Place at CHALLENGE.GOV Electronic Warfare (EW) Battlefield Realism Prize Challenge
VIAVI T/Rx Software-Defined Transceiver System Wins by Enabling Realistic EMS Environments CHANDLER, Ariz., Nov. 4, 2025 /PRNewswire/ -- The VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) T/Rx ...
11-04 19:30
美股牛股 | CMBM涨超27%！与星链携手推出全新集成网络方案；医疗股GH绩后大涨近28%
CMBM涨超27%！与星链携手推出全新集成网络方案；Q3收入同比增长39%超预期，医疗股GH绩后大涨近28%；MTSR涨超22%，拟获诺和诺德要约收购>>
10-31 14:55
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
Viavi Solutions Surpasses Earnings Expectations Amid Growth
Viavi Solutions Inc (($VIAV)) has held its Q1 earnings call. Read on for the ma...
10-31 08:24
